Advocating for Australia’s life sciences. The sector solving the world’s most complex health problems and powering Australia’s economic growth.
We represent Australia's entire life sciences ecosystem from early-stage discovery to translation, development, commercialisation, manufacturing, and global trade.
With a national voice and a growing membership community built on collaboration, we advocate, shape policy, and connect Australian innovators to industry partners, investors and global markets.
Our vision is for Australia to be a global leader in developing and commercialising innovative life science companies.
Employs 1 in every 60 jobs in Australia
2,900 Australian life sciences organisations
Over 1,600 biotech and medtech companies
Together, our members power the full lifecycle of health innovation in Australia — from research discovery to translation, clinical trials, development, manufacturing, commercialisation and global trade.
Join our membership community and connect with Australia’s thriving life sciences ecosystem.
Join us on the Gold Coast this October for Australia’s Biggest Week in Biotech, which brings the full strength of the life sciences ecosystem together in one dynamic, high-impact week with our flagship events — AusBiotech International Conference and AusMedtech Conference, alongside AusBiotech Invest.
Join us for a NSW BioCheers in partnership with McCullough Robertson, bringing the biotech community together for an evening of connection, conversation and capital insight.
Register
Join us for a VIC BioBriefing in partnership with Endpoints Capital and RSM Australia, bringing the biotech community together to unpack the myths, realities, pros and cons of dilutive versus non-dilutive funding. The VIC BioCheers networking function will bring the biotech community together for an evening of connection and further conversation.
Australia’s leading life sciences investment event, part of Australia’s Biggest Week in Biotech.
Join international industry leaders, investors and innovators for a curated two-day program as part of Australia's Biggest Week in Biotech, October 19 to 23, 2026.
AusBiotech’s Board of Directors welcomes Elizabeth Rex, Head of Corporate Affairs at CSL, as a Board Observer.
More than three quarters of Australia’s biotech, medtech and health tech companies recently surveyed said they will be significantly or moderately negatively impacted by the proposed Budget changes to the RDTI.
Connect with leaders, shape the future of the sector, and access the relationships and insights that help organisations grow.